HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection

J Clin Microbiol. 2010 Jan;48(1):281-5. doi: 10.1128/JCM.01573-09. Epub 2009 Nov 11.


HIV-Selectest is a serodiagnostic enzyme immunoassay (EIA), containing p6 and gp41 peptides, designed to differentiate between vaccine-induced antibodies and true infections. A rapid test version of the HIV-Selectest was developed. Both assays detected HIV antibodies in men and women within 2 to 4 weeks of infection, with sensitivity similar to third-generation EIAs.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Viral / blood*
  • Female
  • HIV Infections / diagnosis*
  • HIV Seropositivity*
  • HIV-1 / immunology*
  • Humans
  • Immunoenzyme Techniques / methods*
  • Male
  • Sensitivity and Specificity


  • Antibodies, Viral

Grants and funding